Table 4 Barriers to the implementation of precision medicine according to rheumatologists and fellows (n = 34)
Potential barriers to implementation of precision medicine | Strongly agree or agree N (%)* | Neutral N (%)* | Disagree or strongly disagree N (%)* |
|---|---|---|---|
Not enough scientific evidence | 12 (35.3) | 10 (29.4) | 12 (35.3) |
Lack of guidelines on precision medicine | 15 (44.1) | 10 (29.4) | 9 (26.5) |
Limited availability of tests | 21 (61.7) | 11 (32.4) | 2 (5.9) |
Cost of tests | 20 (58.8) | 11 (32.4) | 3 (8.8) |
Delay obtaining test results | 20 (58.8) | 9 (26.5) | 5 (14.7) |
Insufficient personal knowledge | 10 (29.4) | 12 (35.3) | 12 (35.3) |
Confidentiality of test results | 5 (14.7) | 13 (38.2) | 16 (47.1) |
Impact of test results on patient’s job | 7 (21.2) | 12 (36.4) | 14 (42.5) |
Impact of test results on patient’s insurability | 20 (58.9) | 8 (23.5) | 6 (17.6) |
Impact of test results on patient’s anxiety | 16 (47.1) | 12 (35.3) | 6 (17.6) |
Impact of test results on patient’s family members | 15 (44.2) | 12 (35.3) | 7 (20.5) |